Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity-Reference-Cited by-同舟云学术

Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity

Published:1991-06 Issue:3 Volume:21 Page:323-330
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

RAMADORI G.,ZÖHRENS G.,MANNS M.,RIEDER H.,DIENES H.P.,HESS G.,BÜSCHENFELDE K.-H.MEYER

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.1991.tb01377.x/fullpdf

Reference29 articles.

1. Ethanol and Fibrogenesis in the Liver

2. Liver Fibrosis

3. Radioimmunoassay for type III procollagen peptide and its application to human liver disease

4. Serum concentration of procollagen-III-peptide in comparison with the serum activity of N-acetyl-β-glucosaminidase for diagnosis of the activity of liver fibrosis in patients with chronic active liver diseases

5. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy;Translational Cancer Research;2024-05

2. Extracellular Matrix Remodeling with Focus on Biochemical Markers in Liver Fibrosis: Limitations and Possibilities;The Human Gut-Liver-Axis in Health and Disease;2018-11-10

3. Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression;ESC Heart Failure;2018-10-01

4. Peptide selection for the quantification of P-III-NP in human serum by mass spectrometry;Rapid Communications in Mass Spectrometry;2018-03-05

5. Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease;Liver Cirrhosis - Update and Current Challenges;2017-07-05